reference/16194626

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16194626

Outgoing Links

Predicate	Object
contentType	Journal Article\|Observational Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	841
issn	2151-4658 2151-464X
issueIdentifier	6
pageRange	834-841
publicationName	Arthritis Care & Research
startingPage	834
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d078ef4750b0bad32ea9d3d6f057ad8b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c9715a34c9ccde7ccc72cadee3277b94 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2f27b383cca2565ad499e55bb534e669
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_250b498f949e349ab4cacdedaaf76fe8
bibliographicCitation	Shaw Y, Chang CH, Levesque MC, Donohue JM, Michaud K, Roberts MS. Timing and Impact of Decisions to Adjust Disease-Modifying Antirheumatic Drug Therapy for Rheumatoid Arthritis Patients With Active Disease. Arthritis Care Res (Hoboken). 2018 Jun;70(6):834–41. PMID: 28941147; PMCID: PMC5862728.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4dc10986588ef18773efa12e93b8cdc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_534c781e12d2e1ad1188229399f11fb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5350-3934 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_871c7ed0dc5c80760ef98d64b47653af http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7048-8687 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7352611a87b4e55bfc6ddee27b016fa1
date	2018-04-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC5862728 https://doi.org/10.1002/acr.23418 https://pubmed.ncbi.nlm.nih.gov/28941147
isPartOf	https://portal.issn.org/resource/ISSN/2151-4658 https://portal.issn.org/resource/ISSN/2151-464X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37048
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Timing and Impact of Decisions to Adjust Disease‐Modifying Antirheumatic Drug Therapy for Rheumatoid Arthritis Patients With Active Disease
discusses	http://id.nlm.nih.gov/mesh/M0027742
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D012042 http://id.nlm.nih.gov/mesh/D018501Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8686

Showing number of triples: 1 to 44 of 44.